Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies |
| |
| Authors: | Masayuki Futagami Yoshihito Yokoyama Muneaki Shimada Shinya Sato Etsuko Miyagi Akiko Tozawa-Ono Nao Suzuki Masaki Fujimura Yoichi Aoki Satoru Sagae Toru Sugiyama |
| |
| Institution: | 1.Department of Obstetrics and Gynecology,Hirosaki University Graduate School of Medicine,Hirosaki,Japan;2.Department of Obstetrics and Gynecology, Graduate School of Medicine,Tohoku University,Sendai,Japan;3.Department of Obstetrics and Gynecology,Tottori University School of Medicine,Yonago,Japan;4.Department of Obstetrics and Gynecology,Yokohama City University Hospital,Yokohama,Japan;5.Department of Obstetrics and Gynecology,St. Marianna University School of Medicine,Kawasaki,Japan;6.Department of Obstetrics and Gynecology,Tokyo Medical University Ibaraki Medical Center,Inashiki-gun,Japan;7.Department of Obstetrics and Gynecology, Graduate School of Medical Science,University of the Ryukyus,Nishihara,Japan;8.Gynecologic Oncology,Sapporo West Kojinkai Clinic,Sapporo,Japan;9.Department of Obstetrics and Gynecology,Iwate Medical University,Morioka,Japan |
| |
| Abstract: | The Japanese Gynecologic Oncology Group (JGOG) is leading Japan in the treatment of gynecological malignancies. The JGOG consists of three treatment committees focusing on uterine cervical cancer, endometrial cancer, and ovarian cancer. Each committee makes efforts to improve treatment and diagnosis. In addition, the Supportive and Palliative Care Committee was established in 2015. Novel studies of supportive care and palliative care have been initiated by this committee. Furthermore, surveys about not only treatment results such as overall survival rates but also quality of life (QOL) and cost-effectiveness assessments are performed by the ovarian cancer committee. Improvements of patients’ QOL in the treatment of gynecological malignancies were divided into three concepts as follows: QOL associated with cancer treatment, health care after cancer therapy, and progression of cancer. In this review, we report the contributions and future plans for the improvement of QOL in patients with gynecological malignancies. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
